Modern antibody-based therapeutics

被引：0
|
作者：
Walsh, G [1 ]
机构：
[1] Univ Limerick, Ind Biochem Program, Limerick, Ireland
来源：
BIOPHARM INTERNATIONAL | 2004年 / 17卷 / 12期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：18 / +
页数：7
相关论文
共 50 条
  • [41] Antibody-Based Therapeutics for the Treatment of Renal Cell Carcinoma: Challenges and Opportunities
    Mahmoud, Ahmed M.
    Nabavizadeh, Reza
    Rodrigues Pessoa, Rodrigo
    Garg, Ishita
    Orme, Jacob
    Costello, Brian A.
    Cheville, John
    Lucien, Fabrice
    ONCOLOGIST, 2023, : 297 - 308
  • [42] Through the barricades: overcoming the barriers to effective antibody-based cancer therapeutics
    Dalziel, Martin
    Beers, Stephen A.
    Cragg, Mark S.
    Crispin, Max
    GLYCOBIOLOGY, 2018, 28 (09) : 697 - 712
  • [43] Complement in therapy and disease Regulating the complement system with antibody-based therapeutics
    Melis, Joost P. M.
    Strumane, Kristin
    Ruuls, Sigrid R.
    Beurskens, Frank J.
    Schuurman, Janine
    Parren, Paul W. H. I.
    MOLECULAR IMMUNOLOGY, 2015, 67 (02) : 117 - 130
  • [44] Development and prospects for bispecific antibody-based therapeutics in cancer and other applications
    Lum, Lawrence G.
    Al-Kadhimi, Zaid
    EXPERT OPINION ON DRUG DISCOVERY, 2008, 3 (09) : 1081 - 1097
  • [45] Monoclonal Antibody-Based Candidate Therapeutics Against HIV Type 1
    Chen, Weizao
    Dimitrov, Dimiter S.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2012, 28 (05) : 425 - 434
  • [46] MUC1 antibody-based therapeutics: the promise of cancer immunotherapy
    Pourjafar, Mona
    Samadi, Pouria
    Saidijam, Massoud
    IMMUNOTHERAPY, 2020, 12 (17) : 1269 - 1286
  • [47] An antidote approach to reduce risk and broaden utility of antibody-based therapeutics
    Portnoff, Alyse D.
    Gao, Cuihua
    Borrok, M. Jack
    Gao, Xizhe
    Gao, Changshou
    Rainey, G. Jonah
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2017, 292 (20) : 8498 - 8506
  • [48] Protein Engineering for Improved Pharmacologic Characteristics of Established Monoclonal Antibody-Based Therapeutics
    Meibohm, Bernd
    CLINICAL PHARMACOKINETICS, 2014, 53 (10) : 863 - 864
  • [49] Protein Engineering for Improved Pharmacologic Characteristics of Established Monoclonal Antibody-Based Therapeutics
    Bernd Meibohm
    Clinical Pharmacokinetics, 2014, 53 : 863 - 864
  • [50] Challenges and strategies for next-generation bispecific antibody-based antitumor therapeutics
    Heliang Li
    Phei Er Saw
    Erwei Song
    Cellular & Molecular Immunology, 2020, 17 : 451 - 461
12345